# 13 - References

# References

16
The Maudsley® Prescribing Guidelines in Psychiatry
CHAPTER 1
References
1. Foster P. Neuroleptic equivalence. Pharmaceutical J 1989; 243:431–432.
2. Atkins M, et  al. Chlorpromazine equivalents: a consensus of opinion for both clinical and research implications. Psychiatr Bull 1997; 
21:224–226.
3. Patel MX, et al. How to compare doses of different antipsychotics: a systematic review of methods. Schizophr Res 2013; 149:141–148.
4. Leucht S, et al. Dose equivalents for antipsychotic drugs: the DDD method. Schizophr Bull 2016; 42 Suppl 1:S90–S94.
5. Rothe PH, et al. Dose equivalents for second generation long-­acting injectable antipsychotics: the minimum effective dose method. Schizophr 
Res 2018; 193:23–28.
6. Leucht S, et  al. Dose equivalents for second-­generation antipsychotics: the minimum effective dose method. Schizophr Bull 2014; 
40:314–326.
7. Leucht S, et  al. Dose equivalents for second-­generation antipsychotic drugs: the classical mean dose method. Schizophr Bull 2015; 
41:1397–1402.
8. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003; 64:663–667.
9. McAdam MK, et al. Second International Consensus Study of Antipsychotic Dosing (ICSAD-­2). J Psychopharmacol 2023; 37:982–991.
10. Leucht S, et al. Dose–response meta-­analysis of antipsychotic drugs for acute schizophrenia. Am J Psychiatry 2020; 177:342–353.
11. American Association of Psychiatric Pharmacists. Antipsychotic dose conversion website (last accessed February 2025); https://aapp.
org/guideline/essentials/antipsychotic-­dose-­equivalents.